Gregory Swor, MD
Urogynecology and Reconstructive Pelvic Surgery · Sarasota, FLNPI 1447439245
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 46 manufacturers reported payments, led by Conmed Corporation at 32.3% of the total. Reporting peaked in 2019 at $1,799 and has fallen 73.0% since, to $486 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in FL, where the typical reported total is $5,437.
Across 181 payments — averaging $36.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conmed Corporation$2K
- AbbVie$568
- Cytyc Surgical Products, LLC$450
- Bolder Surgical LLC$316
- Myovant Sciences Inc.$271
- Hologic Sales And Service, LLC$242
- plus $3K from 40 others
Across 481 payments — averaging $2544.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$320K
- Bayer$169K
- Abbott$161K
- Mylan Inc.$129K
- Sumitomo Pharma America, Inc.$92K
- Teva Pharmaceuticals USA, Inc.$79K
- plus $274K from 10 others
What the payments were for
- Consulting fees$2,45037%
- Speaking & faculty fees$3005%
- Food & beverage$3,75157%
- Education$731%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSEAL$1,000
- CONMED HANDHELD INSTRUMENTS$1,000
- JustRight Sealer and CoolSeal Sealer$300
- JustRight Stapler$300
- JustRight Reload$300
- 5mm Tissue Retrieval System$300
- CoolSeal Generator$300
- Desara$152
- FLOSEAL$146
- TISSEEL$146
- SEPRAFILM$146
- ADEPT$146
- MYFEMBREE$125
- IMVEXXY$121
- Orilissa$105
How this compares
$6,573 in reported general payments places this provider in the 50th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
See all urogynecology and reconstructive pelvic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 214 | $12,136 |
| PremarinEstrogens, Conjugated | 16 | $7,543 |
| Estradiol (Twice Weekly)Estradiol | 71 | $6,663 |
| ProgesteroneProgesterone, Micronized | 154 | $5,189 |
| VagifemEstradiol | 12 | $2,961 |
| DottiEstradiol | 15 | $2,720 |
| Estradiol (Once Weekly)Estradiol | 37 | $2,402 |
| Metronidazole | 17 | $720 |
| ValacyclovirValacyclovir Hcl | 27 | $569 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $242 |
| Clobetasol Propionate | 11 | $114 |
| Medroxyprogesterone Acetate | 13 | $106 |
| Fluconazole | 29 | $100 |
| Naproxen | 18 | $52 |
| Tramadol Hcl | 13 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $178 | $7,54316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
Other urogynecology and reconstructive pelvic surgery in Sarasota
- Kristie GreeneSarasota$7K
- Rubin RajuSarasota$4K
- Nathan KowOrlando$116K
- Amir ShariatiCoconut Creek$106K
- Charbel SalamonOrlando$100K
- Allison WymanTampa$69K
- Nicole SzellLargo$54K
- Jose Lazaro WeissOviedo$28K
- Paul PettitJacksonville$27K
- Arash RahiCoconut Creek$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.